A proven approach to speed the path from innovation to commercialization. Available through Larta.
TABA gives SBIR awardees the funds to amplify impact
Opt for TABA funding when you apply for your Phase II SBIR award, and you’ll have extra funds to bring on a professional firm like ours to transform your brand message and website, at no out-of-pocket cost to you. Why do it? Because most innovators are great at engineering amazing products, not at telling the world about them. Our approach amplifies your impact.
Yes, it’s better. Now what?
Inventing and developing an innovative product takes genius. To commercialize it you need to tell the world about it. And that takes a whole different skill set.
The story you tell on your website must be as compelling as the innovation itself. That’s how you get prospective customers, partners and investors interested. And it’s never too early to do it right. Warning: don’t try this at home. Doing it right requires professional help.
Our process:
An analysis of three strategic drivers
Reality2’s proven process starts with an analysis of the three key realities that need to drive any communications initiative:
- What your customers care about
- What your competitors claim
- Your strengths and difference
We collaborate with you to develop a strategic framework that becomes the foundation for all communications, supporting your commercialization goals.
A value proposition so clear, a 6-year-old can understand it
Most technology companies get too complicated too soon when telling their story. A typical take-away is “What do these guys do again?” Instead we simplify and take the customer’s perspective.
We like to say that your message should be so clear, relevant and memorable that even a 6-year-old gets it.
Our work with
Larta companies
Examples of new websites: Strategy, creative, content, copy, design, programming
Reality2 & Larta
Reality2 has been partnering with Larta for over two decades, developing messaging strategies, websites and other materials to support commercialization of innovative technologies.
Talk to your Larta Principal Advisor or Program Manager about connecting you with Reality2.
Client Testimonials
Reality2 knows how to clearly communicate the usefulness and unique value of our particle accelerator innovations to our prospective customers. As our branding and marketing agency, they have been an important collaborator as we commercialize our R&D for national labs and industrial applications such as cancer radiation therapy, national security, and food sterilization.
Salime Max Boucher, CEO, RadiaBeam
Reality2 took us into an important adjacent market with the launch of a spin-off company to develop and market a revolutionary radiation oncology system. The introductory website has had strong impact with customers, potential employees and investors with rapid closing of a $6 million Series A round.
Salime Max Boucher, CEO, Radiabeam/Celestial Technologies
The creativity, professionalism and insight that Reality2 brought to the table gave Food4All a new website that told our story in a relevant and engaging way to each of our audiences. Reality2’s approach is both highly strategic and original. We stand out, with a unified brand voice and clear value proposition. We continue to receive compliments on the new website from prospects to customers to business partners. Everyone who sees it, loves it. We highly recommend Reality2.
Kami Semick, CEO, Food4all
Reality2 really took the time to understand our technology, our market, and the context that matters for both. The team quickly picked up Pancopia’s goals for its web marketing, and developed a messaging strategy that placed our technology in a broader sustainability context while spotlighting our immediate successful application – maximizing the asset value of wastewater in hog production. The website they created for us explains our product’s advantages for its first target market while bringing the bigger picture to life for future markets and applications in a way that resonates with a broad spectrum of stakeholders: industrial partners, customers, users, investors and government agencies. Reality2 delivered an excellent product that fits the company’s mission, pushing forward our commercialization in a meaningful way.
Rachel Willinger, COO, Pancopia
Reality2 developed a messaging strategy and new website for Euclid which did a great job of integrating our diverse products, technologies and services in a dynamic, unified brand context. Later we went back to them for a new multi-panel page to launch our electronic brachytherapy solution. They’re experts at distilling and translating highly technical inputs into clear communication that engages a wide range of audiences.
Darrin Leonhardt, PhD, Chief Innovation Officer, Euclid
Reality2 took a proactive, strategic and creative approach to helping us with our rebranding by analyzing our competition, target customers, and industry environment. They really honed in on our customer’s unmet needs, and were great at translating our product difference into a creative and clearly portrayed story. The Reality2 team is very responsive and continues to support us as our product evolves.
Ryan Nolan, Co-Founder, PhotoniCare
Reality2’s rebranding made the uniqueness of our brand tangible and relevant to our customers. We’re very excited about our new website, which shows how our software removes obstacles so that behavioral health agencies can help more people. The website also supports the special culture we’re building internally. From strategy through creative execution, Reality2 did an excellent job. I highly recommend them.
Peter Flick, CEO, Remarkable Health
Our outdated website didn’t leverage our #1 market leader position. Reality2’s rebranding differentiates us and raises the level of the conversation with an engaging site that shows how our software helps stakeholders address key challenges. The Reality2 team adds value at every step: strategic insights, impactful storytelling and tech support. I like the way they took our rebranding project and ran with it. They know what to do.
CEO, Medicat